A M Tegzess

880 total citations
20 papers, 686 citations indexed

About

A M Tegzess is a scholar working on Epidemiology, Surgery and Virology. According to data from OpenAlex, A M Tegzess has authored 20 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 4 papers in Surgery and 4 papers in Virology. Recurrent topics in A M Tegzess's work include Cytomegalovirus and herpesvirus research (15 papers), HIV Research and Treatment (4 papers) and Herpesvirus Infections and Treatments (3 papers). A M Tegzess is often cited by papers focused on Cytomegalovirus and herpesvirus research (15 papers), HIV Research and Treatment (4 papers) and Herpesvirus Infections and Treatments (3 papers). A M Tegzess collaborates with scholars based in Netherlands, United States and France. A M Tegzess's co-authors include T H Thé, Jurjen Schirm, W.J. van Son, Ruurd Torensma, Wim van der Bij, A. P. van den Berg, M. van der Giessen, W. van der Bij, A. J. M. Donker and J.J. Homan van der Heide and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of the American Society of Nephrology and The Journal of Infectious Diseases.

In The Last Decade

A M Tegzess

20 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A M Tegzess Netherlands 13 509 106 78 78 76 20 686
J. Whelchel United States 11 312 0.6× 79 0.7× 86 1.1× 81 1.0× 20 0.3× 15 503
Bernadette DeArmond United States 7 707 1.4× 77 0.7× 187 2.4× 16 0.2× 65 0.9× 8 861
Nimerta Rajwans Canada 13 216 0.4× 223 2.1× 79 1.0× 9 0.1× 61 0.8× 16 774
M Duffaut France 16 827 1.6× 79 0.7× 46 0.6× 138 1.8× 41 0.5× 49 1.2k
R Duquesnoy United States 16 103 0.2× 320 3.0× 98 1.3× 184 2.4× 118 1.6× 41 832
Tammy Ojo United States 8 282 0.6× 37 0.3× 64 0.8× 85 1.1× 11 0.1× 11 507
Terryl J. Ortego United States 5 1.1k 2.2× 70 0.7× 53 0.7× 5 0.1× 19 0.3× 5 1.5k
Michael I. Abecassis United States 7 335 0.7× 90 0.8× 18 0.2× 61 0.8× 24 0.3× 11 610
Elisa Gabanti Italy 12 171 0.3× 65 0.6× 24 0.3× 15 0.2× 21 0.3× 23 372
Thomas Wendland Switzerland 14 204 0.4× 187 1.8× 40 0.5× 7 0.1× 122 1.6× 18 657

Countries citing papers authored by A M Tegzess

Since Specialization
Citations

This map shows the geographic impact of A M Tegzess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A M Tegzess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A M Tegzess more than expected).

Fields of papers citing papers by A M Tegzess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A M Tegzess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A M Tegzess. The network helps show where A M Tegzess may publish in the future.

Co-authorship network of co-authors of A M Tegzess

This figure shows the co-authorship network connecting the top 25 collaborators of A M Tegzess. A scholar is included among the top collaborators of A M Tegzess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A M Tegzess. A M Tegzess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mark, T W van der, et al.. (1999). Subclinical pneumonitis during cytomegalovirus infection after kidney transplantation. Transplantation Proceedings. 31(1-2). 1388–1390. 1 indexed citations
2.
Broekroelofs, Jan, Coen A. Stegeman, GJ Navis, et al.. (1998). Risk factors for long-term renal survival after renal transplantation. Journal of the American Society of Nephrology. 9(11). 2075–2081. 42 indexed citations
3.
Son, van Willem, et al.. (1993). Cellular immune activation reflects antiviral immunity and is a favorable prognostic marker in patients with cytomegalovirus infection.. PubMed. 25(1 Pt 2). 1419–20. 3 indexed citations
4.
Berg, A. P. van den, et al.. (1992). Monitoring antigenemia is useful in guiding treatment of severe cytomegalovirus disease after organ transplantation. Transplant International. 5(2). 101–107. 24 indexed citations
5.
Tegzess, A M, et al.. (1992). Monitoring antigenemia is useful in guiding treatment of severe cytomegalovirus disease after organ transplantation. Transplant International. 5(2). 101–107. 21 indexed citations
6.
Berg, A. P. van den, W.J. van Son, René A. J. Janssen, et al.. (1992). Recovery from Cytomegalovirus Infection Is Associated with Activation of Peripheral Blood Lymphocytes. The Journal of Infectious Diseases. 166(6). 1228–1235. 40 indexed citations
7.
Rischen-Vos, J., et al.. (1992). Increased morbidity and mortality in patients with diabetes mellitus after kidney transplantation as compared with non-diabetic patients. Nephrology Dialysis Transplantation. 7(5). 433–437. 24 indexed citations
8.
Bilo, Henk, et al.. (1990). Dietary fish oil modifies renal-function during early postoperative rejection episodes in cyclosporine (CSA) treated renal-allograft recipients. Data Archiving and Networked Services (DANS). 1 indexed citations
9.
Heide, J.J. Homan van der, H. J. G. Bilo, A M Tegzess, & A. J. M. Donker. (1990). THE EFFECTS OF DIETARY SUPPLEMENTATION WITH FISH OIL ON RENAL FUNCTION IN CYCLOSPORINE-TREATED RENAL TRANSPLANT RECIPIENTS. Transplantation. 49(3). 523–526. 56 indexed citations
10.
Berg, A. P. van den, W. van der Bij, W.J. van Son, et al.. (1989). CYTOMEGALOVIRUS ANTIGENEMIA AS A USEFUL MARKER OF SYMPTOMATIC CYTOMEGALOVIRUS INFECTION AFTER RENAL TRANSPLANTATION—A REPORT OF 130 CONSECUTIVE PATIENTS. Transplantation. 48(6). 991–994. 144 indexed citations
11.
Son, W.J. van, et al.. (1989). Evidence for pulmonary dysfunction in all patients with symptomatic and asymptomatic cytomegalovirus (CMV) infection after renal transplantation.. PubMed. 21(1 Pt 2). 2065–8. 4 indexed citations
12.
Bij, Wim van der, et al.. (1989). Cytomegalovirus (CMV) antigenemia: rapid diagnosis and relationship with CMV-associated clinical syndromes in renal allograft recipients.. PubMed. 21(1 Pt 2). 2061–4. 22 indexed citations
13.
Bij, W. van der, et al.. (1988). Antigen test for early diagnosis of active cytomegalovirus infection in heart transplant recipients.. PubMed. 7(2). 106–9. 21 indexed citations
14.
Bij, Wim van der, Jurjen Schirm, Ruurd Torensma, et al.. (1988). Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. Journal of Clinical Microbiology. 26(12). 2531–2535. 221 indexed citations
15.
Wee, Pieter M. ter, A M Tegzess, & A. J. M. Donker. (1987). The effect of low-dose dopamine on renal function in uninephrectomized patients: special emphasis on kidney donors before and after nephrectomy.. PubMed. 28(5). 211–6. 15 indexed citations
18.
Middeldorp, Jaap M., et al.. (1985). Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. II. Secondary CMV infections associated with impaired in vitro proliferative responses to mitogens, allogeneic lymphocytes and CMV infected cells.. PubMed. 61(1). 72–9. 5 indexed citations
19.
Middeldorp, Jaap M., et al.. (1985). Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection.. PubMed. 59(3). 709–15. 7 indexed citations
20.
Son, W. J. van, Fokko J. van der Woude, Eric J. van der Jagt, et al.. (1985). Pneumatosis intestinalis in patients after cadaveric kidney transplantation: possible relationship with an active cytomegalovirus infection.. PubMed. 21. 936–40. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026